Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.36 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.36.
Market Cap
8.36T
Revenue
4.52T
Profits
207.03B
PE Ratio
40.36
Profit Margin
4.58%
Dividend Yield
0.43%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 831.78B | -1.06% | 2,082,447 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 573.15B | -0.21% | 7,663,274 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 365.20B | -0.71% | 7,531,832 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 312.72B | -0.88% | 1,724,134 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 296.76B | -1.05% | 6,354,557 | 65.01B |
| 6 | NVS | Novartis AG | 292.19B | 0.27% | 841,529 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 284.10B | 2.85% | 7,971,374 | 447.57B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 191.10B | 3.65% | 1,828,790 | 44.56B |
| 9 | AMGN | Amgen Inc. | 188.79B | -0.34% | 2,547,522 | 36.75B |
| 10 | ABT | Abbott Laboratories | 175.37B | 0.39% | 11,172,878 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 172.57B | 0.03% | 5,086,344 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 165.58B | 1.23% | 12,690,674 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 163.01B | 1.85% | 1,690,991 | 10.06B |
| 14 | PFE | Pfizer Inc. | 155.52B | 1.56% | 44,154,297 | 62.58B |
| 15 | DHR | Danaher Corporation | 138.62B | 3.30% | 4,836,438 | 24.57B |
| 16 | SYK | Stryker Corporation | 132.99B | 2.39% | 2,590,486 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 118.54B | -0.96% | 10,527,653 | 48.19B |
| 18 | GSK | GSK plc | 116.66B | 1.25% | 4,153,645 | 43.97B |
| 19 | MDT | Medtronic plc | 112.98B | 0.91% | 8,276,384 | 35.48B |
| 20 | SNY | Sanofi | 112.24B | 0.43% | 3,562,763 | 54.85B |
| 21 | VRTX | Vertex Pharmaceuticals Incorporated | 111.93B | 0.87% | 1,004,561 | 12.00B |
| 22 | HCA | HCA Healthcare, Inc. | 111.21B | 0.39% | 628,226 | 75.60B |
| 23 | MCK | McKesson Corporation | 105.90B | -0.12% | 554,713 | 397.96B |
| 24 | CVS | CVS Health Corporation | 100.08B | -1.56% | 6,714,616 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 93.90B | 2.25% | 12,225,321 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.60B | -0.32% | 746,951 | 14.34B |
| 27 | CI | The Cigna Group | 72.54B | 1.43% | 1,173,070 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 69.43B | 1.46% | 1,661,886 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.08B | -0.53% | 1,230,016 | 325.78B |
| 30 | MDLN | Medline Inc. | 62.03B | 3.55% | 5,733,619 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 55.74B | -1.44% | 2,890,428 | 28.48B |
| 32 | ZTS | Zoetis Inc. | 50.50B | 1.88% | 3,543,013 | 9.47B |
| 33 | CAH | Cardinal Health, Inc. | 50.40B | -0.62% | 1,394,746 | 244.67B |
| 34 | ARGX | argenx SE | 49.28B | 1.20% | 337,012 | 4.24B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 45.59B | 1.95% | 458,969 | 4.30B |
| 36 | EW | Edwards Lifesciences Corporation | 45.04B | 0.32% | 6,302,459 | 6.07B |
| 37 | BDX | Becton, Dickinson and Company | 44.26B | 0.78% | 3,061,182 | 21.92B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.16B | 3.38% | 967,690 | 3.71B |
| 39 | HLN | Haleon plc | 43.24B | -0.10% | 6,060,631 | 14.85B |
| 40 | ALC | Alcon Inc. | 38.18B | 2.22% | 1,192,055 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.27B | 1.07% | 3,055,877 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 33.90B | -1.30% | 304,168 | 5.34B |
| 43 | GEHC | GE HealthCare Technologies Inc. | 33.69B | 0.89% | 2,325,943 | 20.63B |
| 44 | RMD | ResMed Inc. | 33.40B | 0.61% | 711,301 | 5.40B |
| 45 | A | Agilent Technologies, Inc. | 33.21B | 2.12% | 1,795,339 | 7.07B |
| 46 | INSM | Insmed Incorporated | 32.62B | -2.37% | 2,079,484 | 606.42M |
| 47 | WAT | Waters Corporation | 31.87B | 1.46% | 907,865 | 3.17B |
| 48 | IQV | IQVIA Holdings Inc. | 28.87B | 2.78% | 1,401,693 | 16.31B |
| 49 | NTRA | Natera, Inc. | 28.62B | 4.60% | 1,203,675 | 2.31B |
| 50 | RPRX | Royalty Pharma plc | 27.94B | 1.11% | 2,859,449 | 2.38B |
| 51 | MTD | Mettler-Toledo International Inc. | 27.25B | 1.58% | 145,457 | 4.03B |
| 52 | RVMD | Revolution Medicines, Inc. | 27.01B | 41.35% | 14,720,527 | - |
| 53 | PHG | Koninklijke Philips N.V. | 26.86B | 0.85% | 942,380 | 20.94B |
| 54 | BIIB | Biogen Inc. | 25.88B | 1.96% | 1,414,958 | 9.89B |
| 55 | VEEV | Veeva Systems Inc. | 25.88B | 4.64% | 2,713,333 | 3.20B |
| 56 | UTHR | United Therapeutics Corporation | 25.32B | 1.03% | 482,881 | 3.18B |
| 57 | BNTX | BioNTech SE | 24.45B | 1.26% | 1,361,854 | 3.37B |
| 58 | DXCM | DexCom, Inc. | 24.29B | -1.41% | 5,699,882 | 4.66B |
| 59 | HUM | Humana Inc. | 23.80B | 3.16% | 1,424,185 | 129.66B |
| 60 | STE | STERIS plc | 22.05B | 1.02% | 527,275 | 5.83B |
| 61 | LH | Labcorp Holdings Inc. | 21.71B | 1.25% | 555,031 | 13.95B |
| 62 | DGX | Quest Diagnostics Incorporated | 21.35B | 0.73% | 899,046 | 11.04B |
| 63 | ROIV | Roivant Sciences Ltd. | 20.72B | 2.62% | 3,359,265 | 13.31M |
| 64 | MRNA | Moderna, Inc. | 20.10B | -0.55% | 6,651,817 | 1.94B |
| 65 | ILMN | Illumina, Inc. | 19.41B | 4.99% | 1,350,557 | 4.34B |
| 66 | INCY | Incyte Corporation | 19.02B | -0.54% | 1,186,408 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.72B | 1.33% | 590,354 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 18.45B | 2.38% | 1,784,105 | 8.23B |
| 69 | CNC | Centene Corporation | 18.43B | 0.46% | 4,106,414 | 176.15B |
| 70 | GMAB | Genmab A/S | 17.27B | -0.18% | 2,039,456 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 16.78B | -1.15% | 1,356,649 | 21.31B |
| 72 | VTRS | Viatris Inc. | 16.10B | 2.67% | 7,802,812 | 14.30B |
| 73 | RGC | Regencell Bioscience Holdings Limited | 15.94B | 11.87% | 145,155 | - |
| 74 | SMMT | Summit Therapeutics Inc. | 15.53B | 1.83% | 2,029,088 | - |
| 75 | ASND | Ascendis Pharma A/S | 15.36B | 3.87% | 1,063,596 | 845.52M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 15.10B | 4.40% | 2,589,420 | 502.08M |
| 77 | MEDP | Medpace Holdings, Inc. | 14.31B | 1.56% | 203,880 | 2.53B |
| 78 | SNN | Smith & Nephew plc | 14.27B | 1.55% | 728,642 | 6.16B |
| 79 | COO | The Cooper Companies, Inc. | 13.99B | 0.69% | 1,437,007 | 4.15B |
| 80 | PODD | Insulet Corporation | 13.70B | 0.45% | 665,665 | 2.71B |
| 81 | PEN | Penumbra, Inc. | 13.04B | 0.52% | 379,193 | 1.40B |
| 82 | ALGN | Align Technology, Inc. | 12.94B | 4.35% | 1,031,460 | 4.03B |
| 83 | NBIX | Neurocrine Biosciences, Inc. | 12.68B | -1.99% | 1,093,554 | 2.86B |
| 84 | FMS | Fresenius Medical Care AG | 12.66B | 0.38% | 399,207 | 23.05B |
| 85 | GMED | Globus Medical, Inc. | 12.58B | 2.83% | 1,218,191 | 2.94B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.38B | -0.29% | 1,650,859 | 943.71M |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.06B | 1.17% | 363,762 | 958.40M |
| 88 | JAZZ | Jazz Pharmaceuticals plc | 12.02B | 0.57% | 976,050 | 4.27B |
| 89 | ELAN | Elanco Animal Health Incorporated | 11.92B | 3.16% | 5,716,462 | 4.72B |
| 90 | ENSG | The Ensign Group, Inc. | 11.70B | 0.64% | 221,874 | 5.06B |
| 91 | SOLV | Solventum Corporation | 11.69B | 2.46% | 1,305,954 | 8.33B |
| 92 | EXEL | Exelixis, Inc. | 11.68B | 1.56% | 2,224,727 | 2.32B |
| 93 | UHS | Universal Health Services, Inc. | 11.18B | 1.34% | 731,000 | 17.36B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 10.98B | -0.30% | 1,684,594 | 3.85B |
| 95 | GH | Guardant Health, Inc. | 10.78B | 4.59% | 2,893,057 | 982.02M |
| 96 | EHC | Encompass Health Corporation | 10.69B | 0.29% | 987,741 | 5.94B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.55B | 0.64% | 1,442,167 | 3.22B |
| 98 | RVTY | Revvity, Inc. | 10.36B | 3.17% | 502,905 | 2.86B |
| 99 | DVA | DaVita Inc. | 10.12B | 1.01% | 411,561 | 13.64B |
| 100 | ABVX | ABIVAX Société Anonyme | 9.71B | -3.83% | 1,511,139 | 5.37M |
| 101 | BTSG | BrightSpring Health Services, Inc. | 9.39B | 1.54% | 1,045,492 | 12.91B |
| 102 | MASI | Masimo Corporation | 9.32B | 0.08% | 354,850 | 1.53B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 9.12B | 0.12% | 549,550 | 638.50M |
| 104 | BAX | Baxter International Inc. | 9.10B | 2.80% | 12,110,016 | 11.24B |
| 105 | TECH | Bio-Techne Corporation | 9.00B | 3.58% | 1,847,216 | 1.22B |
| 106 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.93B | -2.07% | 1,765,130 | 1.09B |
| 107 | PCVX | Vaxcyte, Inc. | 8.89B | 1.43% | 950,099 | - |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 8.83B | 0.27% | 269,405 | 7.46M |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.78B | 1.53% | 636,234 | 4.02B |
| 110 | HSIC | Henry Schein, Inc. | 8.72B | 0.86% | 642,379 | 13.18B |
| 111 | QGEN | Qiagen N.V. | 8.67B | 2.49% | 1,470,599 | 2.09B |
| 112 | ICLR | ICON Public Limited Company | 8.43B | 3.33% | 951,123 | 8.10B |
| 113 | ATR | AptarGroup, Inc. | 8.43B | 0.46% | 396,324 | 3.78B |
| 114 | TEM | Tempus AI, Inc. | 8.24B | 7.08% | 5,773,715 | 1.27B |
| 115 | CYTK | Cytokinetics, Incorporated | 8.22B | 2.63% | 1,728,551 | 88.04M |
| 116 | NUVL | Nuvalent, Inc. | 8.15B | 0.92% | 321,750 | - |
| 117 | HALO | Halozyme Therapeutics, Inc. | 7.94B | -1.24% | 1,042,690 | 1.40B |
| 118 | KRYS | Krystal Biotech, Inc. | 7.87B | 3.25% | 240,861 | 389.13M |
| 119 | MOH | Molina Healthcare, Inc. | 7.81B | 2.81% | 1,090,106 | 43.56B |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 7.78B | 3.19% | 213,516 | 2.58B |
| 121 | IBRX | ImmunityBio, Inc. | 7.54B | 0.27% | 9,619,742 | 113.29M |
| 122 | KYMR | Kymera Therapeutics, Inc. | 7.23B | 4.09% | 460,706 | 39.21M |
| 123 | GKOS | Glaukos Corporation | 6.94B | 2.65% | 543,383 | 507.44M |
| 124 | RGEN | Repligen Corporation | 6.91B | 2.07% | 758,123 | 738.26M |
| 125 | BLTE | Belite Bio, Inc | 6.81B | 0.24% | 179,112 | - |
| 126 | HQY | HealthEquity, Inc. | 6.75B | 2.50% | 1,238,184 | 1.31B |
| 127 | ACLX | Arcellx, Inc. | 6.74B | 0.03% | 486,092 | 22.29M |
| 128 | GRFS | Grifols, S.A. | 6.56B | 1.83% | 699,448 | 8.83B |
| 129 | APGE | Apogee Therapeutics, Inc. | 6.41B | 0.54% | 355,798 | - |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.23B | -1.26% | 1,088,545 | 46.02M |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.12B | 0.23% | 2,373,707 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.04% | 6,738,825 | - |
| 133 | BRKR | Bruker Corporation | 5.94B | 3.88% | 1,368,715 | 3.44B |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.93B | 2.87% | 506,820 | 189.76M |
| 135 | BLCO | Bausch + Lomb Corporation | 5.89B | 0.79% | 299,848 | 5.10B |
| 136 | COGT | Cogent Biosciences, Inc. | 5.88B | 0.41% | 2,143,859 | - |
| 137 | PTCT | PTC Therapeutics, Inc. | 5.83B | 2.52% | 665,686 | 1.73B |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | 1.36% | 571,253 | 521.31M |
| 139 | CELC | Celcuity Inc. | 5.82B | 2.78% | 567,849 | - |
| 140 | CGON | CG Oncology, Inc. | 5.72B | - | 879,645 | 4.04M |
| 141 | SRRK | Scholar Rock Holding Corporation | 5.69B | -0.88% | 1,960,277 | - |
| 142 | ALKS | Alkermes plc | 5.61B | 1.17% | 2,182,798 | 1.48B |
| 143 | XENE | Xenon Pharmaceuticals Inc. | 5.59B | 0.34% | 498,400 | 7.50M |
| 144 | AVTR | Avantor, Inc. | 5.53B | 3.54% | 5,187,829 | 6.55B |
| 145 | TFX | Teleflex Incorporated | 5.44B | 4.05% | 640,027 | 1.99B |
| 146 | CAI | Caris Life Sciences, Inc. | 5.41B | 5.98% | 1,961,495 | 812.03M |
| 147 | CHE | Chemed Corporation | 5.34B | 0.46% | 243,426 | 2.53B |
| 148 | PACS | PACS Group, Inc. | 5.33B | 0.41% | 670,388 | 5.29B |
| 149 | LNTH | Lantheus Holdings, Inc. | 5.31B | 1.34% | 1,212,557 | 1.54B |
| 150 | CRSP | CRISPR Therapeutics AG | 5.26B | 7.05% | 1,843,751 | 3.51M |
| 151 | APLS | Apellis Pharmaceuticals, Inc. | 5.22B | 0.12% | 5,828,204 | 1.00B |
| 152 | IMVT | Immunovant, Inc. | 5.11B | 2.53% | 804,138 | - |
| 153 | ERAS | Erasca, Inc. | 5.07B | -4.12% | 14,071,408 | - |
| 154 | TGTX | TG Therapeutics, Inc. | 4.99B | 0.18% | 1,234,507 | 616.29M |
| 155 | SYRE | Spyre Therapeutics, Inc. | 4.97B | 23.36% | 5,360,876 | - |
| 156 | HIMS | Hims & Hers Health, Inc. | 4.82B | 8.85% | 24,679,854 | 2.35B |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | 0.26% | 639,358 | 2.04M |
| 158 | CORT | Corcept Therapeutics Incorporated | 4.61B | 3.32% | 1,261,559 | 761.41M |
| 159 | OSCR | Oscar Health, Inc. | 4.60B | 7.13% | 6,578,595 | 11.70B |
| 160 | OPCH | Option Care Health, Inc. | 4.54B | -0.24% | 1,281,932 | 5.65B |
| 161 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 1,938,602 | 634.21M |
| 162 | SHC | Sotera Health Company | 4.48B | 2.21% | 2,647,053 | 1.16B |
| 163 | NVST | Envista Holdings Corporation | 4.39B | 1.97% | 1,697,751 | 2.72B |
| 164 | RDNT | RadNet, Inc. | 4.36B | 1.44% | 493,969 | 2.04B |
| 165 | ALHC | Alignment Healthcare, Inc. | 4.29B | 2.34% | 1,753,969 | 3.95B |
| 166 | LGND | Ligand Pharmaceuticals Incorporated | 4.26B | 4.16% | 168,533 | 268.09M |
| 167 | WAY | Waystar Holding Corp. | 4.25B | 3.07% | 2,903,362 | 1.10B |
| 168 | MMSI | Merit Medical Systems, Inc. | 4.19B | 3.38% | 591,856 | 1.52B |
| 169 | DOCS | Doximity, Inc. | 4.19B | 7.65% | 2,826,443 | 637.78M |
| 170 | NAMS | NewAmsterdam Pharma Company N.V. | 4.17B | 4.29% | 724,155 | 22.50M |
| 171 | AMRX | Amneal Pharmaceuticals, Inc. | 4.09B | 2.31% | 1,503,954 | 3.02B |
| 172 | VKTX | Viking Therapeutics, Inc. | 4.06B | 2.19% | 1,962,031 | - |
| 173 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.05B | -1.98% | 868,911 | 7.70M |
| 174 | MMED | MiniMed Group, Inc. | 4.04B | 3.38% | 1,445,732 | 2.89B |
| 175 | IRTC | iRhythm Holdings, Inc. | 3.89B | 4.52% | 372,091 | 747.14M |
| 176 | TMDX | TransMedics Group, Inc. | 3.89B | -0.56% | 894,669 | 605.49M |
| 177 | GPCR | Structure Therapeutics Inc. | 3.84B | -0.48% | 467,887 | - |
| 178 | TLX | Telix Pharmaceuticals Limited | 3.77B | 6.64% | 374,957 | 803.79M |
| 179 | STVN | Stevanato Group S.p.A. | 3.77B | 2.14% | 1,836,531 | 1.39B |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.66B | -1.29% | 2,038,007 | 1.07B |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.63B | 3.11% | 689,136 | - |
| 182 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.62B | 0.47% | 350,975 | 677.56M |
| 183 | BLLN | BillionToOne, Inc. | 3.62B | -3.00% | 395,738 | 305.11M |
| 184 | LIVN | LivaNova PLC | 3.53B | 2.87% | 644,877 | 1.39B |
| 185 | LQDA | Liquidia Corporation | 3.42B | 0.78% | 697,665 | 158.32M |
| 186 | LEGN | Legend Biotech Corporation | 3.27B | -2.59% | 1,763,029 | 1.03B |
| 187 | BKD | Brookdale Senior Living Inc. | 3.23B | 0.37% | 2,044,007 | 3.05B |
| 188 | ICUI | ICU Medical, Inc. | 3.23B | 2.90% | 300,671 | 2.23B |
| 189 | DYN | Dyne Therapeutics, Inc. | 3.14B | 1.71% | 1,522,108 | - |
| 190 | VERA | Vera Therapeutics, Inc. | 3.12B | -2.95% | 1,191,525 | - |
| 191 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.09B | 1.60% | 1,107,334 | 588.99M |
| 192 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | 0.12% | 294,931 | 451.36M |
| 193 | TWST | Twist Bioscience Corporation | 3.09B | 5.16% | 981,728 | 391.56M |
| 194 | DNLI | Denali Therapeutics Inc. | 3.08B | 0.99% | 1,107,623 | - |
| 195 | TNGX | Tango Therapeutics, Inc. | 3.08B | 8.07% | 4,071,289 | 62.38M |
| 196 | ORKA | Oruka Therapeutics, Inc. | 3.04B | 3.02% | 1,518,128 | - |
| 197 | TXG | 10x Genomics, Inc. | 3.01B | 1.33% | 2,684,015 | 642.82M |
| 198 | BEAM | Beam Therapeutics Inc. | 3.00B | 10.03% | 3,345,557 | 139.74M |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | -0.37% | 812,871 | 376.07M |
| 200 | ITGR | Integer Holdings Corporation | 2.99B | 3.08% | 236,580 | 1.85B |
| 201 | HNGE | Hinge Health, Inc. | 2.98B | 6.83% | 758,008 | 587.86M |
| 202 | PRVA | Privia Health Group, Inc. | 2.89B | 2.86% | 844,803 | 2.12B |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 2.88B | 7.61% | 10,039,099 | 218.71M |
| 204 | CON | Concentra Group Holdings Parent, Inc. | 2.88B | 2.14% | 650,539 | 2.16B |
| 205 | SUPN | Supernus Pharmaceuticals, Inc. | 2.88B | -1.44% | 347,305 | 718.95M |
| 206 | ALMS | Alumis Inc. | 2.86B | -2.30% | 1,238,669 | 24.05M |
| 207 | TVTX | Travere Therapeutics, Inc. | 2.84B | 6.01% | 2,501,793 | 490.73M |
| 208 | RCUS | Arcus Biosciences, Inc. | 2.81B | 0.22% | 755,142 | 247.00M |
| 209 | HAE | Haemonetics Corporation | 2.75B | 3.40% | 361,996 | 1.32B |
| 210 | RLAY | Relay Therapeutics, Inc. | 2.73B | 2.14% | 2,812,238 | 15.36M |
| 211 | SLNO | Soleno Therapeutics, Inc. | 2.72B | 0.02% | 3,054,341 | 190.41M |
| 212 | PBH | Prestige Consumer Healthcare Inc. | 2.69B | 0.51% | 464,057 | 1.10B |
| 213 | MANE | Veradermics, Incorporated | 2.66B | 3.72% | 671,474 | - |
| 214 | NHC | National HealthCare Corporation | 2.65B | -0.73% | 84,274 | 1.52B |
| 215 | LMAT | LeMaitre Vascular, Inc. | 2.62B | 0.48% | 158,262 | 249.60M |
| 216 | ELVN | Enliven Therapeutics, Inc. | 2.62B | -3.29% | 1,134,225 | - |
| 217 | IRON | Disc Medicine, Inc. | 2.61B | 3.23% | 395,269 | - |
| 218 | WRBY | Warby Parker Inc. | 2.61B | 2.21% | 1,902,993 | 871.91M |
| 219 | KOD | Kodiak Sciences Inc. | 2.59B | -2.69% | 1,015,388 | - |
| 220 | VCYT | Veracyte, Inc. | 2.58B | 4.34% | 912,116 | 517.15M |
| 221 | IMNM | Immunome, Inc. | 2.56B | 4.38% | 1,070,545 | 6.94M |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.56B | 1.09% | 691,118 | 1.55M |
| 223 | HCM | HUTCHMED (China) Limited | 2.52B | 0.20% | 22,408 | 548.51M |
| 224 | LFST | LifeStance Health Group, Inc. | 2.52B | 0.94% | 876,824 | 1.42B |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.50B | 0.87% | 165,167 | 1.45B |
| 226 | ADMA | ADMA Biologics, Inc. | 2.47B | 7.01% | 5,438,695 | 510.17M |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.44B | 2.35% | 2,423,930 | 3.31B |
| 228 | PAHC | Phibro Animal Health Corporation | 2.42B | 2.92% | 329,400 | 1.46B |
| 229 | ZLAB | Zai Lab Limited | 2.40B | 3.19% | 449,266 | 460.16M |
| 230 | XRAY | DENTSPLY SIRONA Inc. | 2.40B | 2.65% | 3,031,671 | 3.68B |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.36B | -1.57% | 3,194,868 | 874.84M |
| 232 | HTFL | HeartFlow, Inc. | 2.35B | 1.78% | 1,013,655 | 176.03M |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | 2.32B | 1.42% | 1,472,452 | 673.00M |
| 234 | NKTR | Nektar Therapeutics | 2.31B | 3.81% | 880,122 | 55.23M |
| 235 | AAPG | Ascentage Pharma Group International | 2.31B | 0.47% | 1,880 | 82.08M |
| 236 | SRPT | Sarepta Therapeutics, Inc. | 2.29B | 2.88% | 1,926,557 | 2.20B |
| 237 | MLYS | Mineralys Therapeutics, Inc. | 2.24B | 2.03% | 652,826 | - |
| 238 | OGN | Organon & Co. | 2.22B | -3.28% | 14,082,120 | 6.22B |
| 239 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.09% | 920,724 | 158.18M |
| 240 | DFTX | Definium Therapeutics, Inc. | 2.22B | 3.34% | 2,022,645 | - |
| 241 | ADPT | Adaptive Biotechnologies Corporation | 2.18B | 10.48% | 3,126,094 | 276.98M |
| 242 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | -0.78% | 884,635 | 172.35M |
| 243 | BHC | Bausch Health Companies Inc. | 2.14B | 2.14% | 803,667 | 10.27B |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | 1.90% | 913,956 | 283.06M |
| 245 | AHG | Akso Health Group | 2.10B | 6.99% | 177,297 | 14.84M |
| 246 | STOK | Stoke Therapeutics, Inc. | 2.07B | 2.10% | 772,262 | 184.42M |
| 247 | SEM | Select Medical Holdings Corporation | 2.03B | 0.12% | 920,194 | 5.45B |
| 248 | NEOG | Neogen Corporation | 1.99B | -2.97% | 3,673,142 | 870.56M |
| 249 | CAPR | Capricor Therapeutics, Inc. | 1.99B | 10.71% | 2,308,165 | 11.13M |
| 250 | ANAB | AnaptysBio, Inc. | 1.98B | -1.95% | 602,151 | 234.60M |
| 251 | GRAL | GRAIL, Inc. | 1.97B | 5.28% | 546,987 | 147.17M |
| 252 | AGIO | Agios Pharmaceuticals, Inc. | 1.94B | 0.70% | 693,824 | 54.03M |
| 253 | ZYME | Zymeworks Inc. | 1.93B | -0.57% | 512,726 | 105.97M |
| 254 | OCUL | Ocular Therapeutix, Inc. | 1.93B | 0.80% | 2,846,153 | 51.95M |
| 255 | TYRA | Tyra Biosciences, Inc. | 1.92B | 1.02% | 1,223,929 | - |
| 256 | SION | Sionna Therapeutics, Inc. | 1.88B | 10.24% | 382,801 | - |
| 257 | AORT | Artivion, Inc. | 1.87B | 2.50% | 337,611 | 441.33M |
| 258 | GLPG | Galapagos NV | 1.85B | 0.56% | 131,801 | 1.31B |
| 259 | PVLA | Palvella Therapeutics, Inc. | 1.85B | 1.48% | 178,128 | - |
| 260 | ESTA | Establishment Labs Holdings Inc. | 1.84B | 4.54% | 234,232 | 211.08M |
| 261 | MESO | Mesoblast Limited | 1.84B | -2.00% | 300,442 | 65.38M |
| 262 | PHVS | Pharvaris N.V. | 1.82B | 4.69% | 417,307 | - |
| 263 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.82B | 0.67% | 1,022,829 | -665.00K |
| 264 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | 4.27% | 8,786,873 | 74.68M |
| 265 | WGS | GeneDx Holdings Corp. | 1.79B | 2.28% | 519,434 | 427.54M |
| 266 | INVA | Innoviva, Inc. | 1.78B | 0.88% | 548,525 | 411.33M |
| 267 | MD | Pediatrix Medical Group, Inc. | 1.77B | 1.68% | 598,168 | 1.91B |
| 268 | VCEL | Vericel Corporation | 1.75B | 2.20% | 751,426 | 276.26M |
| 269 | AXGN | Axogen, Inc. | 1.74B | 4.72% | 497,457 | 225.21M |
| 270 | ADUS | Addus HomeCare Corporation | 1.72B | 3.12% | 256,356 | 1.42B |
| 271 | TRVI | Trevi Therapeutics, Inc. | 1.71B | 1.06% | 869,613 | - |
| 272 | ATEC | Alphatec Holdings, Inc. | 1.70B | 3.21% | 2,614,429 | 764.16M |
| 273 | NTLA | Intellia Therapeutics, Inc. | 1.68B | 5.71% | 3,298,280 | 67.67M |
| 274 | HRMY | Harmony Biosciences Holdings, Inc. | 1.68B | 0.55% | 376,065 | 868.45M |
| 275 | SGRY | Surgery Partners, Inc. | 1.68B | 1.39% | 650,724 | 3.31B |
| 276 | AHCO | AdaptHealth Corp. | 1.67B | 1.23% | 1,353,924 | 3.24B |
| 277 | RAPP | Rapport Therapeutics, Inc. | 1.66B | 1.40% | 145,004 | - |
| 278 | NRIX | Nurix Therapeutics, Inc. | 1.65B | -0.75% | 981,003 | 71.78M |
| 279 | ANIP | ANI Pharmaceuticals, Inc. | 1.63B | -0.06% | 274,105 | 883.37M |
| 280 | GENB | Generate Biomedicines, Inc. | 1.63B | 12.18% | 377,731 | 31.89M |
| 281 | NUVB | Nuvation Bio Inc. | 1.61B | 2.17% | 1,957,785 | 62.90M |
| 282 | OCS | Oculis Holding AG | 1.60B | -0.66% | 215,429 | 1.51M |
| 283 | IMCR | Immunocore Holdings plc | 1.60B | 1.35% | 582,169 | 400.02M |
| 284 | OMCL | Omnicell, Inc. | 1.59B | 1.77% | 281,281 | 1.18B |
| 285 | DMRA | Damora Therapeutics, Inc. | 1.59B | 1.84% | 238,474 | - |
| 286 | INSP | Inspire Medical Systems, Inc. | 1.58B | 1.67% | 613,084 | 911.98M |
| 287 | UFPT | UFP Technologies, Inc. | 1.57B | 1.06% | 177,354 | 602.80M |
| 288 | MBX | MBX Biosciences, Inc. | 1.56B | 5.84% | 300,117 | - |
| 289 | PRGO | Perrigo Company plc | 1.56B | 4.14% | 3,064,561 | 4.25B |
| 290 | ARDX | Ardelyx, Inc. | 1.55B | 2.43% | 2,963,942 | 407.32M |
| 291 | SNDA | Sonida Senior Living, Inc. | 1.55B | 1.75% | 487,911 | 336.39M |
| 292 | BHVN | Biohaven Ltd. | 1.52B | 10.36% | 2,288,583 | - |
| 293 | VRDN | Viridian Therapeutics, Inc. | 1.51B | -1.00% | 1,860,367 | 70.85M |
| 294 | SVRA | Savara Inc. | 1.50B | 4.59% | 1,184,086 | - |
| 295 | NBTX | Nanobiotix S.A. | 1.50B | 5.97% | 53,610 | 38.27M |
| 296 | VIR | Vir Biotechnology, Inc. | 1.49B | -2.00% | 1,651,190 | 68.56M |
| 297 | PGEN | Precigen, Inc. | 1.48B | 0.24% | 1,703,224 | 9.68M |
| 298 | IMTX | Immatics N.V. | 1.46B | 4.22% | 311,821 | 56.67M |
| 299 | ATRC | AtriCure, Inc. | 1.45B | 1.52% | 643,430 | 534.53M |
| 300 | BCAX | Bicara Therapeutics Inc. | 1.45B | 4.83% | 429,698 | - |
| 301 | ENOV | Enovis Corporation | 1.43B | 1.80% | 782,454 | 2.25B |
| 302 | ASTH | Astrana Health, Inc. | 1.43B | 4.52% | 391,372 | 3.18B |
| 303 | IOVA | Iovance Biotherapeutics, Inc. | 1.43B | -6.49% | 17,946,413 | 263.50M |
| 304 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | 0.40% | 799,008 | 123.67M |
| 305 | AVAH | Aveanna Healthcare Holdings Inc. | 1.40B | 3.38% | 958,985 | 2.43B |
| 306 | OLMA | Olema Pharmaceuticals, Inc. | 1.39B | -1.06% | 795,596 | - |
| 307 | ATAI | AtaiBeckley Inc. | 1.38B | 4.12% | 2,340,940 | 4.09M |
| 308 | HROW | Harrow, Inc. | 1.38B | 3.26% | 402,110 | 272.30M |
| 309 | TNDM | Tandem Diabetes Care, Inc. | 1.38B | 4.80% | 1,110,943 | 1.01B |
| 310 | WVE | Wave Life Sciences Ltd. | 1.37B | 1.11% | 2,644,804 | 42.73M |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.36B | 2.74% | 1,274,488 | 2.50M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.35B | -1.54% | 675,433 | 1.84B |
| 313 | PGNY | Progyny, Inc. | 1.33B | 4.17% | 1,187,294 | 1.29B |
| 314 | STAA | STAAR Surgical Company | 1.33B | 1.51% | 1,845,894 | 239.44M |
| 315 | ARDT | Ardent Health, Inc. | 1.33B | -1.38% | 265,400 | 6.32B |
| 316 | PRCT | PROCEPT BioRobotics Corporation | 1.32B | 1.12% | 1,835,060 | 308.05M |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.32B | 2.62% | 728,861 | - |
| 318 | NVAX | Novavax, Inc. | 1.32B | -0.12% | 2,774,053 | 1.12B |
| 319 | PLSE | Pulse Biosciences, Inc. | 1.29B | 1.34% | 194,521 | 350.00K |
| 320 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | 0.46% | 559,030 | - |
| 321 | TSHA | Taysha Gene Therapies, Inc. | 1.27B | -1.56% | 1,583,973 | 9.77M |
| 322 | NNNN | Anbio Biotechnology | 1.25B | 5.31% | 22,529 | 8.65M |
| 323 | ZBIO | Zenas BioPharma, Inc. | 1.25B | 2.94% | 434,211 | 10.00M |
| 324 | DBVT | DBV Technologies S.A. | 1.25B | 7.53% | 394,437 | 5.64M |
| 325 | NVCR | NovoCure Limited | 1.22B | 1.32% | 770,443 | 655.35M |
| 326 | EYPT | EyePoint, Inc. | 1.21B | 2.33% | 956,165 | 31.37M |
| 327 | PHAR | Pharming Group N.V. | 1.20B | -0.76% | 37,934 | 376.13M |
| 328 | IRMD | IRADIMED CORPORATION | 1.20B | 0.15% | 120,064 | 83.81M |
| 329 | USPH | U.S. Physical Therapy, Inc. | 1.18B | 2.43% | 140,043 | 773.34M |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.18B | 5.22% | 422,829 | - |
| 331 | ALVO | Alvotech | 1.16B | 2.49% | 269,380 | 588.90M |
| 332 | CNMD | CONMED Corporation | 1.16B | 4.68% | 406,967 | 1.37B |
| 333 | MPLT | MapLight Therapeutics, Inc. | 1.16B | -1.57% | 328,442 | - |
| 334 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | 0.42% | 722,286 | 780.57M |
| 335 | INBX | Inhibrx Biosciences, Inc. | 1.13B | 2.91% | 213,653 | 1.30M |
| 336 | QURE | uniQure N.V. | 1.12B | 16.51% | 2,097,281 | 16.10M |
| 337 | ABCL | AbCellera Biologics Inc. | 1.11B | 3.39% | 2,916,241 | 75.13M |
| 338 | GERN | Geron Corporation | 1.11B | 3.59% | 23,450,019 | 183.88M |
| 339 | INNV | InnovAge Holding Corp. | 1.10B | -0.73% | 275,366 | 915.37M |
| 340 | KMTS | Kestra Medical Technologies, Ltd. | 1.10B | 4.98% | 248,974 | 83.72M |
| 341 | QDEL | QuidelOrtho Corporation | 1.09B | 16.10% | 2,112,895 | 2.73B |
| 342 | PNTG | The Pennant Group, Inc. | 1.09B | 2.09% | 192,734 | 947.71M |
| 343 | BFLY | Butterfly Network, Inc. | 1.09B | 4.14% | 3,548,889 | 97.61M |
| 344 | AZTA | Azenta, Inc. | 1.07B | 5.04% | 758,007 | 595.03M |
| 345 | CLOV | Clover Health Investments, Corp. | 1.07B | 5.18% | 3,832,199 | 1.92B |
| 346 | SEPN | Septerna, Inc. | 1.05B | 1.08% | 218,205 | 45.95M |
| 347 | ORIC | ORIC Pharmaceuticals, Inc. | 1.04B | 2.46% | 1,522,536 | - |
| 348 | NEO | NeoGenomics, Inc. | 1.04B | 4.03% | 2,217,178 | 727.33M |
| 349 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | 2.05% | 1,194,689 | 291.85M |
| 350 | GHRS | GH Research PLC | 1.01B | 3.94% | 214,839 | - |
| 351 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 0.32% | 973,507 | 175.11M |
| 352 | KALV | KalVista Pharmaceuticals, Inc. | 1.00B | 1.03% | 426,342 | 73.62M |
| 353 | URGN | UroGen Pharma Ltd. | 987.28M | -5.98% | 689,411 | 109.79M |
| 354 | IVA | Inventiva S.A. | 986.13M | -4.75% | 398,420 | 9.31M |
| 355 | CRON | Cronos Group Inc. | 979.63M | -0.39% | 760,965 | 146.59M |
| 356 | EVO | Evotec SE | 977.90M | 5.70% | 120,481 | 925.65M |
| 357 | PCRX | Pacira BioSciences, Inc. | 974.19M | 1.13% | 392,586 | 726.41M |
| 358 | EVMN | Evommune, Inc. | 972.86M | 5.88% | 257,638 | 13.00M |
| 359 | BLFS | BioLife Solutions, Inc. | 971.31M | 1.87% | 394,973 | 96.21M |
| 360 | AMPH | Amphastar Pharmaceuticals, Inc. | 969.11M | 4.86% | 577,852 | 719.89M |
| 361 | AKTS | Aktis Oncology, Inc. | 958.49M | 2.73% | 205,369 | 6.50M |
| 362 | SSII | SS Innovations International, Inc. | 957.71M | 11.40% | 37,095 | 42.48M |
| 363 | CTMX | CytomX Therapeutics, Inc. | 949.02M | - | 6,291,402 | 76.20M |
| 364 | TDOC | Teladoc Health, Inc. | 941.85M | 2.35% | 4,086,531 | 2.53B |
| 365 | CMPX | Compass Therapeutics, Inc. | 936.46M | 0.58% | 2,348,974 | 850.00K |
| 366 | ANNX | Annexon, Inc. | 932.36M | -0.68% | 1,509,788 | - |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 929.38M | 3.76% | 420,360 | 1.02B |
| 368 | JBIO | Jade Biosciences, Inc. | 911.86M | 3.35% | 784,887 | - |
| 369 | JANX | Janux Therapeutics, Inc. | 906.39M | -0.20% | 705,046 | 10.00M |
| 370 | OPK | OPKO Health, Inc. | 888.11M | 0.86% | 2,776,122 | 606.88M |
| 371 | CERT | Certara, Inc. | 887.75M | 4.32% | 3,285,989 | 418.84M |
| 372 | INMD | InMode Ltd. | 886.39M | 3.40% | 842,768 | 370.50M |
| 373 | XNCR | Xencor, Inc. | 885.20M | -2.82% | 771,655 | 125.58M |
| 374 | FTRE | Fortrea Holdings Inc. | 877.03M | 2.18% | 676,904 | 2.72B |
| 375 | TALK | Talkspace, Inc. | 865.45M | 0.19% | 1,116,366 | 228.87M |
| 376 | VOR | Vor Biopharma Inc. | 865.34M | 3.23% | 1,555,677 | - |
| 377 | CGEM | Cullinan Therapeutics, Inc. | 862.50M | -1.99% | 1,113,317 | - |
| 378 | CDNA | CareDx, Inc. | 861.97M | 4.86% | 504,361 | 379.81M |
| 379 | SANA | Sana Biotechnology, Inc. | 856.64M | 3.88% | 4,689,355 | - |
| 380 | SLS | SELLAS Life Sciences Group, Inc. | 854.81M | - | 4,053,803 | - |
| 381 | ABUS | Arbutus Biopharma Corporation | 854.24M | 5.30% | 1,391,807 | 14.08M |
| 382 | TBPH | Theravance Biopharma, Inc. | 849.63M | 0.92% | 279,956 | 107.46M |
| 383 | SDGR | Schrödinger, Inc. | 845.30M | 0.70% | 1,350,094 | 255.87M |
| 384 | SLDB | Solid Biosciences Inc. | 825.50M | 4.61% | 2,144,016 | - |
| 385 | DRUG | Bright Minds Biosciences Inc. | 823.16M | 1.95% | 138,097 | - |
| 386 | ANRO | Alto Neuroscience, Inc. | 822.60M | 13.04% | 787,388 | - |
| 387 | OMER | Omeros Corporation | 819.32M | -0.96% | 797,850 | - |
| 388 | MNKD | MannKind Corporation | 815.22M | 2.72% | 2,558,087 | 348.97M |
| 389 | IART | Integra LifeSciences Holdings Corporation | 798.08M | 3.43% | 763,753 | 1.64B |
| 390 | SGP | SpyGlass Pharma, Inc. | 797.89M | 15.04% | 124,392 | - |
| 391 | SPRY | ARS Pharmaceuticals, Inc. | 794.38M | -0.62% | 854,352 | 84.28M |
| 392 | MRVI | Maravai LifeSciences Holdings, Inc. | 786.63M | -0.33% | 1,923,187 | 185.74M |
| 393 | MGTX | MeiraGTx Holdings plc | 784.33M | 7.36% | 437,011 | 81.39M |
| 394 | BVS | Bioventus Inc. | 783.32M | 3.97% | 301,151 | 568.09M |
| 395 | TLRY | Tilray Brands, Inc. | 781.05M | 2.28% | 2,857,715 | 858.28M |
| 396 | RLMD | Relmada Therapeutics, Inc. | 774.08M | 1.23% | 1,318,752 | - |
| 397 | KURA | Kura Oncology, Inc. | 770.24M | 0.58% | 800,787 | 67.48M |
| 398 | DSGN | Design Therapeutics, Inc. | 761.65M | 1.56% | 132,013 | - |
| 399 | FBRX | Forte Biosciences, Inc. | 749.03M | -12.80% | 523,529 | - |
| 400 | ALLO | Allogene Therapeutics, Inc. | 745.96M | 12.50% | 87,821,040 | 22.00K |
| 401 | CMPS | COMPASS Pathways plc | 743.89M | 4.34% | 1,725,577 | - |
| 402 | NUTX | Nutex Health Inc. | 740.53M | 5.17% | 149,697 | 875.26M |
| 403 | GDRX | GoodRx Holdings, Inc. | 736.54M | -1.83% | 1,424,050 | 796.85M |
| 404 | TENX | Tenax Therapeutics, Inc. | 729.36M | 0.49% | 220,203 | - |
| 405 | LXRX | Lexicon Pharmaceuticals, Inc. | 724.49M | -0.58% | 838,325 | 49.80M |
| 406 | CBLL | CeriBell, Inc. | 720.45M | 5.45% | 215,229 | 89.06M |
| 407 | BIOA | BioAge Labs, Inc. | 718.51M | - | 452,837 | 9.00M |
| 408 | AMN | AMN Healthcare Services, Inc. | 718.23M | 3.97% | 577,245 | 2.73B |
| 409 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 716.29M | 6.55% | 931,423 | - |
| 410 | OMDA | Omada Health, Inc. | 714.18M | 6.22% | 851,384 | 260.21M |
| 411 | CSTL | Castle Biosciences, Inc. | 712.86M | 1.73% | 251,165 | 344.23M |
| 412 | ETON | Eton Pharmaceuticals, Inc. | 710.76M | -1.18% | 608,544 | 79.95M |
| 413 | EHAB | Enhabit, Inc. | 709.11M | - | 590,766 | 1.06B |
| 414 | GYRE | Gyre Therapeutics, Inc. | 702.20M | 4.06% | 49,899 | 116.59M |
| 415 | ARVN | Arvinas, Inc. | 676.71M | -2.22% | 656,913 | 262.60M |
| 416 | AVNS | Avanos Medical, Inc. | 675.76M | 2.47% | 413,166 | 701.20M |
| 417 | DRTS | Alpha Tau Medical Ltd. | 672.39M | 4.80% | 364,737 | - |
| 418 | PSNL | Personalis, Inc. | 660.52M | 4.82% | 1,319,146 | 69.65M |
| 419 | PRME | Prime Medicine, Inc. | 648.11M | 6.71% | 1,809,876 | 4.63M |
| 420 | LBRX | LB Pharmaceuticals Inc | 643.36M | 4.48% | 304,211 | - |
| 421 | SIBN | SI-BONE, Inc. | 618.31M | 9.03% | 792,621 | 200.93M |
| 422 | OCGN | Ocugen, Inc. | 604.84M | 1.70% | 5,693,846 | 4.41M |
| 423 | HSTM | HealthStream, Inc. | 597.99M | 2.46% | 215,730 | 304.06M |
| 424 | CBIO | Crescent Biopharma, Inc. | 597.52M | -0.99% | 208,106 | 10.84M |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 595.16M | 0.55% | 906,019 | 296.15M |
| 426 | CTKB | Cytek Biosciences, Inc. | 590.05M | 1.32% | 616,014 | 201.49M |
| 427 | PROK | ProKidney Corp. | 588.74M | - | 2,787,012 | 893.00K |
| 428 | MDXG | MiMedx Group, Inc. | 582.38M | 1.29% | 943,432 | 418.63M |
| 429 | CRMD | CorMedix Inc. | 578.65M | 1.10% | 906,514 | 311.71M |
| 430 | LYEL | Lyell Immunopharma, Inc. | 578.54M | 10.76% | 169,006 | 36.00K |
| 431 | KYTX | Kyverna Therapeutics, Inc. | 573.72M | 6.03% | 606,282 | - |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 570.68M | 2.64% | 715,702 | 106.47M |
| 433 | BWAY | BrainsWay Ltd. | 570.27M | 3.38% | 100,201 | 52.23M |
| 434 | ESPR | Esperion Therapeutics, Inc. | 570.12M | 2.30% | 5,851,844 | 403.14M |
| 435 | TECX | Tectonic Therapeutic, Inc. | 562.55M | -2.47% | 218,635 | - |
| 436 | UPB | Upstream Bio, Inc. | 556.72M | -2.48% | 412,646 | 2.85M |
| 437 | PRTA | Prothena Corporation plc | 555.02M | -1.81% | 334,052 | 9.68M |
| 438 | RIGL | Rigel Pharmaceuticals, Inc. | 553.64M | 2.64% | 284,585 | 294.28M |
| 439 | TCMD | Tactile Systems Technology, Inc. | 551.47M | 3.46% | 183,514 | 329.52M |
| 440 | EMBC | Embecta Corp. | 548.38M | 4.63% | 674,896 | 1.08B |
| 441 | ACRS | Aclaris Therapeutics, Inc. | 542.08M | -3.47% | 1,148,595 | 7.83M |
| 442 | ZURA | Zura Bio Limited | 538.92M | 0.53% | 567,912 | - |
| 443 | VALN | Valneva SE | 536.53M | -0.81% | 22,305 | 205.07M |
| 444 | AVR | Anteris Technologies Global Corp. | 535.45M | 9.15% | 921,164 | 1.91M |
| 445 | EIKN | Eikon Therapeutics, Inc. | 534.35M | 9.67% | 409,360 | - |
| 446 | PHR | Phreesia, Inc. | 520.13M | 6.20% | 2,202,306 | 480.59M |
| 447 | FULC | Fulcrum Therapeutics, Inc. | 514.82M | 2.38% | 570,384 | 80.00M |
| 448 | IMMX | Immix Biopharma, Inc. | 513.69M | 4.64% | 605,069 | - |
| 449 | FDMT | 4D Molecular Therapeutics, Inc. | 512.56M | 2.34% | 553,931 | 85.21M |
| 450 | STTK | Shattuck Labs, Inc. | 511.69M | -2.17% | 314,567 | 1.00M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 511.37M | 2.70% | 970,778 | 44.55M |
| 452 | AGMB | AgomAb Therapeutics NV | 507.84M | -1.14% | 137,915 | - |
| 453 | OFIX | Orthofix Medical Inc. | 507.83M | 2.18% | 354,865 | 822.31M |
| 454 | LRMR | Larimar Therapeutics, Inc. | 504.87M | 0.21% | 1,438,904 | - |
| 455 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 456 | NPCE | NeuroPace, Inc. | 500.96M | 4.35% | 82,716 | 99.99M |
| 457 | TRDA | Entrada Therapeutics, Inc. | 500.04M | 2.89% | 90,399 | 25.42M |
| 458 | ENGN | enGene Therapeutics Inc. | 497.73M | 3.19% | 210,061 | - |
| 459 | VSTM | Verastem, Inc. | 497.15M | 6.59% | 2,347,370 | 30.91M |
| 460 | CATX | Perspective Therapeutics, Inc. | 495.61M | -2.68% | 954,300 | 884.00K |
| 461 | IVVD | Invivyd, Inc. | 486.42M | -2.27% | 4,103,201 | 53.43M |
| 462 | ADCT | ADC Therapeutics SA | 484.04M | 1.87% | 537,979 | 81.36M |
| 463 | KMDA | Kamada Ltd. | 483.41M | -0.59% | 33,971 | 180.46M |
| 464 | VREX | Varex Imaging Corporation | 477.88M | 1.97% | 283,040 | 854.40M |
| 465 | CTNM | Contineum Therapeutics, Inc. | 476.41M | -0.85% | 96,690 | - |
| 466 | BBNX | Beta Bionics, Inc. | 473.69M | 19.98% | 1,208,812 | 100.25M |
| 467 | LXEO | Lexeo Therapeutics, Inc. | 472.68M | 6.69% | 905,324 | - |
| 468 | ABSI | Absci Corporation | 466.71M | 2.35% | 2,600,242 | 2.80M |
| 469 | RGNX | REGENXBIO Inc. | 466.62M | 2.73% | 805,969 | 170.44M |
| 470 | ASMB | Assembly Biosciences, Inc. | 463.83M | 2.89% | 143,103 | 72.30M |
| 471 | XOMA | XOMA Royalty Corporation | 460.54M | 5.20% | 229,871 | 52.15M |
| 472 | VTVT | vTv Therapeutics Inc. | 460.39M | 1.48% | 85,762 | 17.00K |
| 473 | AVIR | Atea Pharmaceuticals, Inc. | 454.93M | 0.71% | 215,344 | - |
| 474 | ANL | Adlai Nortye Ltd. | 445.02M | 8.06% | 817,852 | 5.40M |
| 475 | AURA | Aura Biosciences, Inc. | 443.28M | 1.62% | 337,076 | - |
| 476 | FLGT | Fulgent Genetics, Inc. | 441.32M | 6.03% | 601,997 | 322.67M |
| 477 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.90M | 4.66% | 464,808 | - |
| 478 | PACB | Pacific Biosciences of California, Inc. | 437.90M | 8.21% | 4,765,840 | 160.01M |
| 479 | STRO | Sutro Biopharma, Inc. | 433.90M | 1.28% | 391,280 | 102.48M |
| 480 | MYGN | Myriad Genetics, Inc. | 429.20M | 5.52% | 986,692 | 824.50M |
| 481 | KIDS | OrthoPediatrics Corp. | 428.48M | 6.14% | 170,849 | 236.35M |
| 482 | ARMP | Armata Pharmaceuticals, Inc. | 428.24M | 5.13% | 26,257 | 4.90M |
| 483 | ANGO | AngioDynamics, Inc. | 426.82M | 4.49% | 327,892 | 313.73M |
| 484 | PRTC | PureTech Health plc | 426.35M | 7.91% | 8,380 | 6.39M |
| 485 | EBS | Emergent BioSolutions Inc. | 425.55M | 3.52% | 551,064 | 742.90M |
| 486 | AUNA | Auna S.A. | 424.83M | -2.38% | 215,736 | 1.30B |
| 487 | VNDA | Vanda Pharmaceuticals Inc. | 423.21M | -0.83% | 1,016,707 | 216.11M |
| 488 | ALT | Altimmune, Inc. | 420.24M | -0.31% | 2,122,551 | 41.00K |
| 489 | ENTA | Enanta Pharmaceuticals, Inc. | 414.11M | 1.13% | 71,982 | 66.98M |
| 490 | CGC | Canopy Growth Corporation | 413.53M | 2.86% | 10,401,611 | 203.04M |
| 491 | CLYM | Climb Bio, Inc. | 412.24M | 2.62% | 437,114 | - |
| 492 | BNTC | Benitec Biopharma Inc. | 411.06M | 5.08% | 103,847 | - |
| 493 | CYH | Community Health Systems, Inc. | 409.63M | -2.86% | 1,341,500 | 12.49B |
| 494 | IPSC | Century Therapeutics, Inc. | 407.97M | 0.89% | 638,499 | 109.16M |
| 495 | YDES | YD Bio Limited | 403.64M | -8.31% | 43,320 | 510.36K |
| 496 | RCKT | Rocket Pharmaceuticals, Inc. | 397.21M | 4.30% | 3,397,797 | - |
| 497 | IRD | Opus Genetics, Inc. | 396.30M | 3.92% | 499,355 | 14.20M |
| 498 | ZNTL | Zentalis Pharmaceuticals, Inc. | 394.38M | -15.89% | 6,626,463 | 26.87M |
| 499 | AKBA | Akebia Therapeutics, Inc. | 393.78M | 5.00% | 1,738,737 | 236.20M |
| 500 | AUTL | Autolus Therapeutics plc | 391.23M | -1.34% | 753,293 | 75.39M |